Medical tech firm Becton Dickinson to buy C.R. Bard for $24B

Medical technology firm Becton, Dickinson and Co. says it has reached an agreement to buy competitor C.R. Bard Inc. in a cash-and-stock deal worth $24 billion

from ABC News: Health http://ift.tt/2oApPb3
via HEALTH